Journal Title：Medical Molecular Morphology

Medical Molecular Morphology is an international forum for researchers in both basic and clinical medicine to present and discuss new research on the structural mechanisms and the processes of health and disease at the molecular level. The structures of molecules, organelles, cells, tissues, and organs determine their normal function. Disease is thus best understood in terms of structural changes in these different levels of biological organization, especially in molecules and molecular interactions as well as the cellular localization of chemical components. Medical Molecular Morphology welcomes articles on basic or clinical research in the fields of cell biology, molecular biology, and medical, veterinary, and dental sciences using techniques for structural research such as electron microscopy, confocal laser scanning microscopy, enzyme histochemistry, immunohistochemistry, radioautography, X-ray microanalysis, and in situ hybridization.

Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.

醫(yī)學分子形態(tài)學是基礎醫(yī)學和臨床醫(yī)學研究人員的國際論壇，旨在介紹和討論分子水平上健康和疾病的結構機制和過程的新研究。分子、細胞器、細胞、組織和器官的結構決定了它們的正常功能。因此，疾病最好從這些不同生物組織層次的結構變化來理解，尤其是分子和分子相互作用以及化學成分的細胞定位。 《醫(yī)學分子形態(tài)學》歡迎發(fā)表細胞生物學、分子生物學、醫(yī)學、獸醫(yī)學和牙科科學領域的基礎或臨床研究文章，這些研究使用電子顯微鏡、共聚焦激光掃描顯微鏡、酶組織化學、免疫組織化學、放射自顯影、X 射線微分析和原位雜交等結構研究技術。

提交出版的手稿必須包含一份聲明，說明所有人類研究均已由適當?shù)膫惱砦瘑T會審查，因此均按照 1964 年《赫爾辛基宣言》適當版本中規(guī)定的道德標準進行。文中還應明確說明，所有人在參與研究之前均已知情同意。應省略可能泄露研究對象身份的細節(jié)。

Medical Molecular Morphology創(chuàng)刊于1993年，由Springer Singapore出版商出版，收稿方向涵蓋醫(yī)學 - 病理學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業(yè)影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 12周，或約稿 ，影響因子指數(shù)1.2，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。